Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe they went dark by the advice from one of those watchdog groups with three capital letters in their name. The doctor has proved himself as being overzealous when it comes to "Forward Looking" statements and few becoming reality.
You have some good ideas for the patent utilization in the CBD segment; however, I don't think there's anything going on, just a product that is way too expensive and it turns brown in ninety days.
Remember that guy who thought he bought the patent from Phillips? Keough was his name and losing was his game, E I O was his name O!
I haven't checked the pace monitor site lately, do you know if the Doc is still defending his honor against the Super-Hero? I'll check and let you know.
Yes, we seen a lot of crap here, some good at one time, but now it's a mystery. Or should I say a misery.
Someone just dumped 288,397 shares and it dropped to $2.04 and instantly recovered and trading higher. Expect much higher prices on the near future with that kind of a demand. Maybe "Institutional Buying".
The FDA is going to move the new Nano-flu through the phase 3 process on the fast-track. There's a lot of eyeballs watching this one including the Big-Fish.
Just to add: If you or anyone else that has been following this stock is truly a believer in the product, then it doesn't matter how low the PPS will go between now and when they do release a PR, you would just average down and sit on it. It would also be self-defeating to shore up the PPS with small purchases at the end of the day to maintain price.
The key to trading pennies is to time the buy early after the PR and sell just past the top of the bell curve. It's hard to determine where the top is, but a good sign is when the volume tappers off due to the buyers drying up. This is how this stock has been trading for the past 14 or so months.
I don't believe there will be a big deal, they would have had one drop on their lap already. It's all about milking the cow while it's still warm.
Yes, you are correct. They know that not posting the fins will cause red flags, but that helps them to achieve thier goal as well.
A PR will likely raise the PPS so they need to convert first. We don't know where the 90 day average share price window begins and ends.
"SOON"!
You maybe correct. Look at the glass ceiling formed that large buys can't break through.
The bright side to the equation is that each time they have diluted, the company bought out other companies to increase their market share and also it's padding the bottom line.
My gut feeling is VDRM will not have a press release until all convertible shares issued become unrestricted and the PPS is at a low price to convert as many shares as they can. This is how they scam the unsuspecting investor. Seeing that they went dark, we don't know if they issued shares or not, the 12/31/17 report didn't show the 250 million shares dump until 5 months later and I think that is what is happening now as well.
Just my opinion based on past facts.
How would you know? What facts do you have to backup your claims?
They have to pay for these services somehow. The revenues are slim after everyone else gets paid and they have interest payments as well.
Don't get me wrong, I would love to see this workout for you and all the other investors here, but the company is failing on all fronts.
(K) Convertible Notes Payable – Brewer
On January 3, 2018, the Company entered into a services agreement with a consultant for business development and marketing services, pursuant to which the Company agreed to issue the consultant total 20,000,000 shares of common stock of the Company and a convertible promissory note in amount of $48,000 for services rendered (“Brewer Note”).
Brewer Note bears interest at a rate of 10% per annum with 20% default charge and 20% default rate. Brewer Note is convertible at the Note Holder’s option into the shares of the common stock of the Company at a conversion price of 70% of the market, and the Note Holder should be reimbursed for the conversion cost by adding $500 to the Principal of Brewer Note for each note conversion effected by Note Holder.
VIADERMA, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2018 (UNAUDITED)
- 21 -
NOTE 6 – CONVERTIBLE NOTES PAYABLE (CONTINUED)
(K) Convertible Notes Payable – Brewer (continued)
The Company determined that the conversion features contained in Brewer Note carrying value represents a freestanding derivative instrument that meets the requirements for liability classification under ASC 815. As a result, the fair value of the derivative financial instrument in the note is reflected in the Company’s balance sheet as a liability. The fair value of the derivative financial instrument of the convertible note was measured using the Black-Scholes valuation model at the inception date of the note and will do so again on each subsequent balance sheet date. Any changes in the fair value of the derivative financial instruments are recorded as non-operating, non-cash income or expense at each balance sheet date. The derivative liabilities will be reclassified into additional paid in capital upon conversion.
The table below sets forth the assumptions for Black-Scholes valuation model on March 31, 2018.
Reporting Date
Fair Value Term (Years)
Assumed Conversion Price
Market Price on Issuance Date
Volatility Percentage
Risk-free Rate
03/31/2018 $ 56,690 0.76 $0.006 $0.0106 168% 0.0209
As a result, Brewer Note was discounted in the amount of $60,000 and amortized over the remaining life of this Note. During the three months ended March 31, 2018, the Company recorded interest expenses related to Brewer Note in amount of $1,160, and amortization of debt discounts in amount of $11,441. This resulted in accrued interest of $1,160 and an unamortized debt discount of $36,559 as of March 31, 2018.
https://backend.otcmarkets.com/otcapi/company/financial-report/193710/content
The Brewer Group is doing the marketing.
You just attacked me, and no I'm not todd, he's getting the coffee. NOT!
You may want to review the TOS agreement. If you attack other posters, you are in violation of the TOS, and the post is removed. This goes for all messages positive or negative.
You may want to dig a little deeper into the research you did.
Last year the company was trading converted shares to finance marketing, accounting and other cost. We didn't get disclosure until 5 months later when the company finally released the late EOY fins. They added 250M shares as they promoted phony statements about huge sales increases month over month.
I would also like to lead you to the fact that the recipients of the convertible shares all work out of the same office in Plantation Florida and were using addresses from their satellite offices.
This company is also the second attempt to make a viable company from a single product. They promoted that they were going to launch additional products based on the technology, but they never actually made it to the shelves, other than a trial basis of Elixr. (I think the guy they were partnering with in Canada saw through their BS and bailed out of the deal.
Do more DD and you will see I'm not BS you and I have NO interest in putting another dollar into this scam.
The problem with VDRM is not the people warning others that this company is failing, the problem is that it is truly failing. Blame the management for your loss, they're the ones who failed to perform, if this wasn't true the PPS would be going up no matter what negative comment are said. Look at this issue on the flipside; If I just bought this stock based on unfounded "News coming soon" comments and I became trapped in this stink hole, who do you think I'm going to be upset with? That's right, the people who actually mislead me, with illusions of grandeur.
It appears to be Big Sells or better known as Dumps when the PPS goes down from the previous trade. Pretty obvious to most, but tell yourself whatever it takes to feel good about your holdings.
If No News by EOW PPS range $.0019-.0022
"Look at the Financials", I wish I could, but the great and wonderful Doctor has gone dark.
When he did post Fins, one of my biggest disappointments was the revenues. The doc was bosting how much the sales were increasing month by month early last year and when it showed up on the "Fins" it had little impact. There's little meat on the bone after the after everyone else get paid out and the folks paying the bills are the fooled shareholders.
There's nothing to see here but "RED"!
Black for the day @ $.0029 and red for the year, closed 12/29/2018 @ $.0135 for a 460% loss for the year and triple the outstanding shares.
Looking in is much better than looking out of the VDRM interment camp.
WoW! 300 share paint job for $.87, that's a great buy!
Something isn't adding up with WFT. JMHO
Here comes the "Tax-loss" sales. Hold on tight most faithful ones!
Take a look at today's chart in 5 min. The volume that had pushed the PPS to $.275 is significantly larger than the down volume. MNGA is in an accumulation mode in this price range.
Expect MNGA PPS to continue to rise.
Last year we were making money, this year they went dark. Big difference between the two.
Day #70 since you made this prediction, any comment?
If there was a future for VDRM we would be talking about it.
"Soon!"
"Tax-loss" day! (It's not going to be pretty around here by EOD).
Why, we gave them a year if not more? The Doc has you on a hook. You might rip off your lip, but you much shake off that hook.
How about "Truth", a rare concept in OTC stocks.
Maybe it will spark a fire under the Doc's ass to report the financials, good or bad.
You can handle the truth, right?
Warning! This company has posted limited financial disclosure through the OTC Disclosure & News Service or is late in their filing obligations with the SEC.
I think there is something seriously wrong with the company and management is afraid to say anything. Think out it people, the financials should be out by now, there is no good excuse after 45 days late.
You couldn't have been more wrong with that analogy.
It was long ago, when I took my family to a small zoo when we noticed a fairly large crowd gathered in front of the monkey gage. As we approached it was apparent that this crowd was being entertained by a male monkey masturbating next to a cold shouldered female sitting next to him and the crowd was going crazy with cheering on the monkey.
So, to say people are not entertained by a Monkey f@cking couldn't be more off the mark, but I think your right about what we are all here watching.
Great quote! "Lipstick on a pig" works too.
Small lots and no news is a sign of desperate shareholders lowering PPS cost with the hope they can start this campfire of wet leaves with a Bic lighter. Just my intuition and experience giving me insight.
So fess up slops, how many did you add today?
PS. I put the text in bold so you understand my point better.
I'm looking forward to the CEO laying out the business plan for 2019. The upside far outweighs the downside considering the outlook for CBDD.
This is a great time to buy in!
The only people buying this stock are the shareholder themselves in an attempt to maintain the current price level; apparently a feeble attempt.